BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1133 related articles for article (PubMed ID: 10318916)

  • 1. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway.
    Shtutman M; Zhurinsky J; Simcha I; Albanese C; D'Amico M; Pestell R; Ben-Ze'ev A
    Proc Natl Acad Sci U S A; 1999 May; 96(10):5522-7. PubMed ID: 10318916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone.
    Natsume H; Sasaki S; Kitagawa M; Kashiwabara Y; Matsushita A; Nakano K; Nishiyama K; Nagayama K; Misawa H; Masuda H; Nakamura H
    Biochem Biophys Res Commun; 2003 Sep; 309(2):408-13. PubMed ID: 12951064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin. Regulation by histone deacetylase 1.
    Henderson BR; Galea M; Schuechner S; Leung L
    J Biol Chem; 2002 Jul; 277(27):24258-64. PubMed ID: 11986304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
    Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
    Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling through beta-catenin and Lef/Tcf.
    Novak A; Dedhar S
    Cell Mol Life Sci; 1999 Oct; 56(5-6):523-37. PubMed ID: 11212302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
    Tetsu O; McCormick F
    Nature; 1999 Apr; 398(6726):422-6. PubMed ID: 10201372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf.
    Albanese C; Wu K; D'Amico M; Jarrett C; Joyce D; Hughes J; Hulit J; Sakamaki T; Fu M; Ben-Ze'ev A; Bromberg JF; Lamberti C; Verma U; Gaynor RB; Byers SW; Pestell RG
    Mol Biol Cell; 2003 Feb; 14(2):585-99. PubMed ID: 12589056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation.
    Orsulic S; Huber O; Aberle H; Arnold S; Kemler R
    J Cell Sci; 1999 Apr; 112 ( Pt 8)():1237-45. PubMed ID: 10085258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of multipotent stem cells during morphogenesis of small intestinal crypts of Lieberkuhn is perturbed by stimulation of Lef-1/beta-catenin signaling.
    Wong MH; Huelsken J; Birchmeier W; Gordon JI
    J Biol Chem; 2002 May; 277(18):15843-50. PubMed ID: 11854293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin.
    Simcha I; Shtutman M; Salomon D; Zhurinsky J; Sadot E; Geiger B; Ben-Ze'ev A
    J Cell Biol; 1998 Jun; 141(6):1433-48. PubMed ID: 9628899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor-2 induces Lef/Tcf-dependent transcription in human endothelial cells.
    Holnthoner W; Pillinger M; Groger M; Wolff K; Ashton AW; Albanese C; Neumeister P; Pestell RG; Petzelbauer P
    J Biol Chem; 2002 Nov; 277(48):45847-53. PubMed ID: 12235165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine phosphorylation translocates beta-catenin from cell-->cell interface to the cytoplasm, but does not significantly enhance the LEF-1-dependent transactivating function.
    Kim K; Lee KY
    Cell Biol Int; 2001; 25(5):421-7. PubMed ID: 11401329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1.
    Sampson EM; Haque ZK; Ku MC; Tevosian SG; Albanese C; Pestell RG; Paulson KE; Yee AS
    EMBO J; 2001 Aug; 20(16):4500-11. PubMed ID: 11500377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A functional screen in human cells identifies UBF2 as an RNA polymerase II transcription factor that enhances the beta-catenin signaling pathway.
    Grueneberg DA; Pablo L; Hu KQ; August P; Weng Z; Papkoff J
    Mol Cell Biol; 2003 Jun; 23(11):3936-50. PubMed ID: 12748295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation.
    Persad S; Troussard AA; McPhee TR; Mulholland DJ; Dedhar S
    J Cell Biol; 2001 Jun; 153(6):1161-74. PubMed ID: 11402061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma.
    Rockman SP; Currie SA; Ciavarella M; Vincan E; Dow C; Thomas RJ; Phillips WA
    J Biol Chem; 2001 Nov; 276(48):45113-9. PubMed ID: 11572874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase(s) mediate(s) NO-induced dissociation of beta-catenin from membrane bound E-cadherin and formation of nuclear beta-catenin/LEF-1 complex.
    Mei JM; Borchert GL; Donald SP; Phang JM
    Carcinogenesis; 2002 Dec; 23(12):2119-22. PubMed ID: 12507936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of beta-catenin-lymphocyte enhancer-binding factor signaling.
    Easwaran V; Song V; Polakis P; Byers S
    J Biol Chem; 1999 Jun; 274(23):16641-5. PubMed ID: 10347231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1.
    Aoki M; Hecht A; Kruse U; Kemler R; Vogt PK
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):139-44. PubMed ID: 9874785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters.
    Gustavson MD; Crawford HC; Fingleton B; Matrisian LM
    Mol Carcinog; 2004 Nov; 41(3):125-39. PubMed ID: 15457508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.